The issues you raise relating to Selective Serotonin Re-Uptake Inhibitors (SSRIs) has been the subject of extensive correspondence between you and the Medicines Control Agency. Both I and the Agency's staff have given many hours of our time to providing you with information and explanations and the correspondence is substantially greater than that currently displayed on your website. I, myself, am not prepared to rehearse the arguments yet again but if you insist on continuing the debate you should do so through the Medicines Control Agency.

I am unclear as to whether you have made formal complaint, to the Committee on Standards in Public Life, about the CSM's activities. If so I would appreciate a copy and an outline of the basis for your complaint.

Best wishes